Cannapharmarx (CPMD) Stock Statistics & Valuation Metrics

Cannapharmarx has a market cap or net worth of $1.42M. The enterprise value is $22.67M.

Cannapharmarx has 678,501,400 shares outstanding. The number of shares has decreased by -2.65% in one year.

Cannapharmarx’s return on equity (ROE) is 0.37 and return on invested capital (ROIC) is 35.23%.

The current PE Ratio of Cannapharmarx is ―. Cannapharmarx’s PEG ratio is -0.05.

In the last 12 months, Cannapharmarx had revenue of 1.36M and earned -11.13M in profits. Earnings per share was -0.02.

In the last 12 months, operating cash flow was -431.38K and capital expenditures 187.72K, giving a free cash flow of -436.90K billion.

Cannapharmarx pays an annual dividend of ―, resulting in a dividend yield of ―

Cannapharmarx upcoming earnings date is May 25, 2027, TBA (Confirmed).

Cannapharmarx as a current ratio of 0.04, with Debt / Equity ratio of -69.29%

In the past 12 months, Cannapharmarx has paid 0.00 in taxes.

Cannapharmarx EV to EBITDA ratio is -7.41, with an EV/FCF ratio of -30.32.

Cannapharmarx has $633.00 in cash and marketable securities with $20.97M in debt, giving a net cash position of -$20.97M billion.

Gross margin is -120.40%, with operating margin of -245.77%, and net profit margin of -817.19%.

The average price target for Cannapharmarx is ―, which is 11.43% higher than the current price. The consensus rating is ―